Literature DB >> 1654406

Treatment of malignant brain tumors with focused ultrasound hyperthermia and radiation: results of a phase I trial.

A N Guthkelch1, L P Carter, J R Cassady, K H Hynynen, R P Iacono, P C Johnson, E A Obbens, R B Roemer, J F Seeger, D S Shimm.   

Abstract

Hyperthermia delivered by scanned focused ultrasound was combined with external beam radiation to treat 15 patients with primary malignant tumors of the brain. A preliminary craniectomy was performed to avoid attenuation of the ultrasound beam by the skull, and multiple thermal sensors were employed to ascertain intratumoral temperatures. The target temperature was 42.5 degrees C at the tumor boundary. This was attained at more than one point during every complete treatment, while a mean temperature in excess of 42 degrees C was achieved within the scanned tumor volume during at least 1 treatment in 11 patients. Technical problems and toxicities are described.

Entities:  

Mesh:

Year:  1991        PMID: 1654406     DOI: 10.1007/bf00177540

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  15 in total

1.  Observations on selective brain heating in dogs.

Authors:  A B HARRIS; L ERICKSON; J H KENDIG; S MINGRINO; S GOLDRING
Journal:  J Neurosurg       Date:  1962-06       Impact factor: 5.115

2.  Production of focal destructive lesions in the central nervous system with ultrasound.

Authors:  W J FRY; W H MOSBERG; J W BARNARD; F J FRY
Journal:  J Neurosurg       Date:  1954-09       Impact factor: 5.115

3.  What is a safe heat dose which can be applied to normal brain tissue?

Authors:  P Sminia; J Haveman; B W Ongerboer de Visser
Journal:  Int J Hyperthermia       Date:  1989 Jan-Feb       Impact factor: 3.914

4.  A scanned, focused, multiple transducer ultrasonic system for localized hyperthermia treatments.

Authors:  K Hynynen; R Roemer; D Anhalt; C Johnson; Z X Xu; W Swindell; T Cetas
Journal:  Int J Hyperthermia       Date:  1987 Jan-Feb       Impact factor: 3.914

5.  Influence of nutrient and energy deprivation on cellular response to single and fractionated heat treatments.

Authors:  L E Gerweck; W K Dahlberg; L F Epstein; D S Shimm
Journal:  Radiat Res       Date:  1984-09       Impact factor: 2.841

6.  The role of tissue environmental factors on the kinetics and morphology of tumor cells exposed to hyperthermia.

Authors:  J Overgaard; O S Nielsen
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

7.  Influence of pH on the thermal sensitivity of cultured human glioblastoma cells.

Authors:  L E Gerweck; B Richards
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

8.  Local ionizing radiation with and without microwave induced hyperthermia in superficial malignant tumors in brain.

Authors:  C E Lindholm; E Kjellen; T Landberg; C Mercke; P Nilsson; B Persson
Journal:  Adv Exp Med Biol       Date:  1982       Impact factor: 2.622

9.  Scanned focussed ultrasound hyperthermia: initial clinical results.

Authors:  D S Shimm; K H Hynynen; D P Anhalt; R B Roemer; J R Cassady
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-11       Impact factor: 7.038

10.  Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma.

Authors:  J Overgaard; M Overgaard
Journal:  Int J Hyperthermia       Date:  1987 Nov-Dec       Impact factor: 3.914

View more
  38 in total

Review 1.  Ultrasound enhanced drug delivery to the brain and central nervous system.

Authors:  Meaghan A O'Reilly; Kullervo Hynynen
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

2.  Direct thermal dose control of constrained focused ultrasound treatments: phantom and in vivo evaluation.

Authors:  Dhiraj Arora; Daniel Cooley; Trent Perry; Mikhail Skliar; Robert B Roemer
Journal:  Phys Med Biol       Date:  2005-04-06       Impact factor: 3.609

3.  Evaluation of three-dimensional temperature distributions produced by a low-frequency transcranial focused ultrasound system within ex vivo human skulls.

Authors:  Nathan McDannold; Eun-Joo Park; Chang-Sheng Mei; Eyal Zadicario; Ferenc Jolesz
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2010-09       Impact factor: 2.725

Review 4.  The risk of exposure to diagnostic ultrasound in postnatal subjects: thermal effects.

Authors:  William D O'Brien; Cheri X Deng; Gerald R Harris; Bruce A Herman; Christopher R Merritt; Naren Sanghvi; James F Zachary
Journal:  J Ultrasound Med       Date:  2008-04       Impact factor: 2.153

Review 5.  MR-guided focused ultrasound surgery, present and future.

Authors:  David Schlesinger; Stanley Benedict; Chris Diederich; Wladyslaw Gedroyc; Alexander Klibanov; James Larner
Journal:  Med Phys       Date:  2013-08       Impact factor: 4.071

6.  Development of a spherically focused phased array transducer for ultrasonic image-guided hyperthermia.

Authors:  Jingfei Liu; Josquin Foiret; Douglas N Stephens; Olivier Le Baron; Katherine W Ferrara
Journal:  Phys Med Biol       Date:  2016-06-29       Impact factor: 3.609

7.  Dual-mode IVUS catheter for intracranial image-guided hyperthermia: feasibility study.

Authors:  Carl D Herickhoff; Gerald A Grant; Gavin W Britz; Stephen W Smith
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2010-11       Impact factor: 2.725

Review 8.  Magnetic resonance-guided focused ultrasound: a new technology for clinical neurosciences.

Authors:  Ferenc A Jolesz; Nathan J McDannold
Journal:  Neurol Clin       Date:  2013-11-08       Impact factor: 3.806

9.  Transcranial magnetic resonance imaging- guided focused ultrasound surgery of brain tumors: initial findings in 3 patients.

Authors:  Nathan McDannold; Greg T Clement; Peter Black; Ferenc Jolesz; Kullervo Hynynen
Journal:  Neurosurgery       Date:  2010-02       Impact factor: 4.654

10.  Interaction between microwave-induced brain hyperthermia and high dose rate radiation in the BT4 An brain glioma in rats.

Authors:  B K Krossnes; B C Schem; B Nygaard; O Dahl; O Mella
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.